These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

383 related articles for article (PubMed ID: 15995579)

  • 1. Pneumolysin as a vaccine and drug target in the prevention and treatment of invasive pneumococcal disease.
    Cockeran R; Anderson R; Feldman C
    Arch Immunol Ther Exp (Warsz); 2005; 53(3):189-98. PubMed ID: 15995579
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Streptococcus pneumoniae: epidemiology and risk factors, evolution of antimicrobial resistance, and impact of vaccines.
    Lynch JP; Zhanel GG
    Curr Opin Pulm Med; 2010 May; 16(3):217-25. PubMed ID: 20375783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pneumococcal vaccines: an update on current strategies.
    Bogaert D; Hermans PW; Adrian PV; Rümke HC; de Groot R
    Vaccine; 2004 Jun; 22(17-18):2209-20. PubMed ID: 15149779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Streptococcus pneumoniae: does antimicrobial resistance matter?
    Lynch JP; Zhanel GG
    Semin Respir Crit Care Med; 2009 Apr; 30(2):210-38. PubMed ID: 19296420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New insights into pneumococcal disease.
    Feldman C; Anderson R
    Respirology; 2009 Mar; 14(2):167-79. PubMed ID: 19272081
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antimicrobial-resistant Streptococcus pneumoniae: trends and management.
    Jacobs MR
    Expert Rev Anti Infect Ther; 2008 Oct; 6(5):619-35. PubMed ID: 18847402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibiotic resistance in Streptococcus pneumoniae: what does the future hold?
    Nuermberger EL; Bishai WR
    Clin Infect Dis; 2004 May; 38 Suppl 4():S363-71. PubMed ID: 15127371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Empiric first-line antibiotic treatment of acute otitis in the era of the heptavalent pneumococcal conjugate vaccine.
    Garbutt J; Rosenbloom I; Wu J; Storch GA
    Pediatrics; 2006 Jun; 117(6):e1087-94. PubMed ID: 16740811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of pneumococcal vaccination in children younger than 24 months: a meta-analysis.
    Pavia M; Bianco A; Nobile CG; Marinelli P; Angelillo IF
    Pediatrics; 2009 Jun; 123(6):e1103-10. PubMed ID: 19482744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pneumococcal conjugate vaccines. A review.
    Galiza EP; Heath PT
    Minerva Med; 2007 Apr; 98(2):131-43. PubMed ID: 17519855
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of pneumococcal conjugate vaccine against PCR-positive acute otitis media.
    Palmu AA; Saukkoriipi A; Jokinen J; Leinonen M; Kilpi TM
    Vaccine; 2009 Mar; 27(10):1490-1. PubMed ID: 19168111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A pivotal role for pneumolysin in the immunopathogenesis, treatment and prevention of pneumococcal disease.
    Feldman C; Anderson R
    S Afr Med J; 2007 Nov; 97(11 Pt 3):1141-5. PubMed ID: 18250925
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute bacterial rhinosinusitis and otitis media: changes in pathogenicity following widespread use of pneumococcal conjugate vaccine.
    Benninger MS
    Otolaryngol Head Neck Surg; 2008 Mar; 138(3):274-8. PubMed ID: 18312870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The epidemiology of childhood pneumococcal disease in the United States in the era of conjugate vaccine use.
    Toltzis P; Jacobs MR
    Infect Dis Clin North Am; 2005 Sep; 19(3):629-45. PubMed ID: 16102653
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pneumolysin as a potential therapeutic target in severe pneumococcal disease.
    Anderson R; Feldman C
    J Infect; 2017 Jun; 74(6):527-544. PubMed ID: 28322888
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunizations with pneumococcal surface protein A and pneumolysin are protective against pneumonia in a murine model of pulmonary infection with Streptococcus pneumoniae.
    Briles DE; Hollingshead SK; Paton JC; Ades EW; Novak L; van Ginkel FW; Benjamin WH
    J Infect Dis; 2003 Aug; 188(3):339-48. PubMed ID: 12870114
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Construction and immunological characterization of a novel nontoxic protective pneumolysin mutant for use in future pneumococcal vaccines.
    Kirkham LA; Kerr AR; Douce GR; Paterson GK; Dilts DA; Liu DF; Mitchell TJ
    Infect Immun; 2006 Jan; 74(1):586-93. PubMed ID: 16369015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of antibiotic-resistant Streptococcus pneumoniae infections and the use of pneumococcal conjugate vaccines.
    Picazo JJ
    Clin Microbiol Infect; 2009 Apr; 15 Suppl 3():4-6. PubMed ID: 19366362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Escalation of antimicrobial resistance among Streptococcus pneumoniae: implications for therapy.
    Lynch JP; Zhanel GG
    Semin Respir Crit Care Med; 2005 Dec; 26(6):575-616. PubMed ID: 16388429
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Streptococcus pneumoniae: the role of apoptosis in host defense and pathogenesis.
    Marriott HM; Dockrell DH
    Int J Biochem Cell Biol; 2006; 38(11):1848-54. PubMed ID: 16844403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.